As a result, the serum levels of IL1B, IL6, CXCL8, TNFA and CCL2 were significantly up-regulated in colorectal cancer patients, compared with those in healthy controls, while there is no difference for IL10 between two groups (Fig. 2A). This evidence concerns the gene IL1B and colorectal cancer.